The market is projected to grow from $63.7 billion in 2023 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period. The biomarker market is ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR ...

Following the success of our previous roundtables, during which research leaders exchanged ideas on data issues and how they are overcoming them, this intimate session (limited to 6–8 participants) ...

Company management said they expect the tariff battle with China to cause weakening of $375 million in adjusted operating ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...

Q1 2025 Management View Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 ...

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...

The global effort to combat climate change requires expanding renewable energy technologies. To optimise solar cells, ...